STRS Ohio’s Kiniksa Pharmaceuticals KNSA Stock Holding History

STRS Ohio’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19M	Buy	+18,600	New	+$965K	﹤0.01%	666
2025 Q2	–	Sell	-26,800	Closed	-$595K	–	2255
2025 Q1	$595K	Sell	26,800 -5,600	-17%	-$115K	﹤0.01%	1080
2024 Q4	$641K	Buy	32,400 +5,500	+20%	+$126K	﹤0.01%	1033
2024 Q3	$672K	Sell	26,900 -3,700	-12%	-$90.1K	﹤0.01%	1080
2024 Q2	$571K	Buy	30,600 +2,500	+9%	+$46.8K	﹤0.01%	1147
2024 Q1	$554K	Sell	28,100 -5,200	-16%	-$102K	﹤0.01%	1184
2023 Q4	$584K	Sell	33,300 -1,900	-5%	-$31.2K	﹤0.01%	1187
2023 Q3	$611K	Sell	35,200 -2,100	-6%	-$35.4K	﹤0.01%	1120
2023 Q2	$525K	Sell	37,300 -11,300	-23%	-$151K	﹤0.01%	1260
2023 Q1	$522K	Buy	48,600 +10,500	+28%	+$138K	﹤0.01%	1293
2022 Q4	$570K	Buy	+38,100	New	+$555K	﹤0.01%	1253
2021 Q1	–	Sell	-13,300	Closed	-$235K	–	2227
2020 Q4	$235K	Sell	13,300 -18,500	-58%	-$325K	﹤0.01%	1707
2020 Q3	$487K	Buy	31,800 +8,300	+35%	+$156K	﹤0.01%	1355
2020 Q2	$598K	Sell	23,500 -3,500	-13%	-$73.1K	﹤0.01%	1179
2020 Q1	$417K	Buy	27,000 +13,500	+100%	+$211K	﹤0.01%	1263
2019 Q4	$149K	Hold	13,500	–	–	﹤0.01%	1718
2019 Q3	$114K	Hold	13,500	–	–	﹤0.01%	1745
2019 Q2	$182K	Buy	13,500 +8,600	+176%	+$133K	﹤0.01%	1722
2019 Q1	$88K	Hold	4,900	–	–	﹤0.01%	1809
2018 Q4	$137K	Buy	4,900 +3,000	+158%	+$62.6K	﹤0.01%	1703
2018 Q3	$48K	Buy	+1,900	New	+$36.9K	﹤0.01%	1960

Other funds holding KNSA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

STRS Ohio's KNSA Position: Q2 2026 in Review

STRS Ohio opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 18,600 shares worth $1.19M. The stake represents ﹤0.01% of the portfolio and ranks #666 among its holdings. This is a return to the name: STRS Ohio previously reported a position in KNSA as recently as Q1 2025.

STRS Ohio first reported a position in KNSA in Q3 2018 and has held it in 21 quarters since. 267 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

STRS Ohio held 18,600 shares of Kiniksa Pharmaceuticals worth $1.19M as of Q2 2026.
Kiniksa Pharmaceuticals was a new STRS Ohio position in Q2 2026.
Kiniksa Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #666 holding.
STRS Ohio first reported a position in Kiniksa Pharmaceuticals in Q3 2018 and has held it in 21 quarters since.
267 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.